Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-5.88%
operating margin TTM
3.68%
revenue TTM
196.90 Million
revenue per share TTM
1.19$
valuation ratios | |
|---|---|
| pe ratio | -81.09 |
| peg ratio | -1.49 |
| price to book ratio | -1,472.92 |
| price to sales ratio | 4.45 |
| enterprise value multiple | 46.51 |
| price fair value | -1,472.92 |
profitability ratios | |
|---|---|
| gross profit margin | 83.54% |
| operating profit margin | 3.68% |
| pretax profit margin | -5.88% |
| net profit margin | -5.88% |
| return on assets | -4.22% |
| return on equity | 73.68% |
| return on capital employed | 3.86% |
liquidity ratios | |
|---|---|
| current ratio | 1.93 |
| quick ratio | 1.35 |
| cash ratio | 0.79 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 562.04 |
| operating cycle | 635.76 |
| days of payables outstanding | 54.38 |
| cash conversion cycle | 581.38 |
| receivables turnover | 4.95 |
| payables turnover | 6.71 |
| inventory turnover | 0.65 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.10 |
| debt equity ratio | -44.35 |
| long term debt to capitalization | 1.03 |
| total debt to capitalization | 1.02 |
| interest coverage | 0.33 |
| cash flow to debt ratio | 0.28 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.11 |
| cash per share | 0.52 |
| operating cash flow per share | 0.06 |
| free cash flow operating cash flow ratio | 1.88 |
| cash flow coverage ratios | 0.28 |
| short term coverage ratios | 1.70 |
| capital expenditure coverage ratio | 18.11 |
Frequently Asked Questions
When was the last time Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) reported earnings?
Xeris Biopharma Holdings, Inc. (XERS) published its most recent earnings results on 06-11-2025.
What is Xeris Biopharma Holdings, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)'s trailing twelve months ROE is 73.68%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Xeris Biopharma Holdings, Inc. (XERS) currently has a ROA of -4.22%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did XERS's net profit margin stand at?
XERS reported a profit margin of -5.88% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is XERS's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.93 in the most recent quarter. The quick ratio stood at 1.35, with a Debt/Eq ratio of -44.35.